“…The prevalence of co-morbidities such as insulin resistance, metabolic syndrome and type 2 diabetes (T2D) associated with psoriasis has gained interest in recent years, while most were cross-sectional (Cohen et al, 2008; Driessen et al, 2009; Henseler and Christophers, 1995; Kimball et al, 2008; Lindegard, 1986; Love et al, 2011; Neimann et al, 2006; Pearce et al, 2005) or case-control studies (Brauchli et al, 2008; Gerdes et al, 2008; Gisondi et al, 2007; Naldi et al, 2008; Shapiro et al, 2007; Sommer et al, 2006; Vena et al, 2010; Wu et al, 2008), and inflammation seems to be an underlying mechanism (Davidovici et al, 2010; Hu et al, 2004; Pradhan et al, 2001). …”